ArticleFrontiers in immunology2026
MRPL3 is identified as a prognostic biomarker and therapeutic target in lung adenocarcinoma via a lactylation-disulfidptosis gene signature model and experimental validation.
Lan Yin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.